The comments come days after Pfizer Inc said its experimental COVID-19 vaccine is more than 90% effective based on initial trial results and that it expects to file for U.S. emergency authorization this month. The vaccine candidate uses synthetic messenger RNA to activate the immune system against the virus and needs to be kept at minus 70 degrees Celsius (-94 F) or below.